Souhaitez-vous accéder aux communiqués récents ?

Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Drug Repurposing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Drug Repurposing...

Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "GLP-1R Agonists - Label Extensions/Drug Repurposing: Market Overview" report has been added to ResearchAndMarkets.com's offering.This report is a...

Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "AI in Pharmacovigilance Training Course" has been added to ResearchAndMarkets.com's offering. This course will provide a comprehensive introduction...

Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market Report 2025" has been added to ResearchAndMarkets.com's offering.The biosimulation market size is forecast to see rapid growth in...

Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: AI in drug discovery" report has been added to ResearchAndMarkets.com's offering. This report consolidates the latest...

Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering.This study...

Taglich Brothers, Inc. announces that it has initiated coverage of Cosmos Health Inc. (NASDAQ: COSM).

MEDIA RELEASE LifeArc announces £5 million drug repurposing programme for motor neuron disease LifeArc is launching new £5m programme to help find new treatments for motor neuron disease (MND).The...

VANCOUVER, British Columbia, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical...

Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Artificial Intelligence in Drug Discovery" report has been added to ResearchAndMarkets.com's offering. The current report will...